Regulation of immune responses by pharmacological modulation of major histocompatibility complex (MHC)-restricted antigen presentation
MedPharmRes · 31.03.2026 · 10 (1) · 1-9
DOI: 10.32895/mpr.26.00007 ↗Kurz gefasst
Fachartikel in der Zeitschrift MedPharmRes, online erschienen am 31.03.2026. Verfasst von Sang-Hyun Kim und 1 weiteren Autor:innen. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Major histocompatibility complex (MHC)-restricted antigen presentation is a fundamental process that initiates and shapes T cell-mediated immune responses. While most current immunomodulatory therapies target downstream signaling pathways of T cell activation, growing evidence highlights antigen presentation as a critical upstream determinant of T cell specificity, magnitude, and functional outcome. Pharmacological agents that modulate antigen processing, peptide loading, and MHC surface expression can profoundly alter T cell priming and immune responses. In this review, we briefly summarize the molecular mechanisms governing MHC class I- and class II-restricted antigen presentation, including cross-presentation by professional antigen-presenting cells. We then discuss emerging pharmacological modulators that regulate T cell responses by targeting MHC-restricted antigen presentation pathways, including calcineurin inhibitors, proteasome and immunoproteasome inhibitors, epigenetic regulators, endoplasmic reticulum stress modulators, and autophagy-targeting agents. By highlighting how these agents influence antigen processing and presentation independently of direct T cell signaling, we propose pharmacological modulation of MHC-restricted antigen presentation as an underexplored yet powerful strategy for immune intervention.
Zitieren
APA
Kim, S., & Lee, C. (2026). Regulation of immune responses by pharmacological modulation of major histocompatibility complex (MHC)-restricted antigen presentation. MedPharmRes, 10(1), 1-9. https://doi.org/10.32895/mpr.26.00007
Vancouver
Kim S, Lee C. Regulation of immune responses by pharmacological modulation of major histocompatibility complex (MHC)-restricted antigen presentation. MedPharmRes. 2026;10(1):1-9. doi:10.32895/mpr.26.00007
BibTeX
@article{Kim2026,
author = {Kim, Sang-Hyun and Lee, Chong-Kil},
title = {Regulation of immune responses by pharmacological modulation of major histocompatibility complex (MHC)-restricted antigen presentation},
journal = {MedPharmRes},
year = {2026},
volume = {10},
number = {1},
pages = {1--9},
doi = {10.32895/mpr.26.00007}
}
EUVIMED